PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS

The review concerns on the testing of platelet function in Chd patients receiving antiplatelet medications.  the results are shown of the main large-scale studies demonstrating the relationship of the residual platelet activity level with the development of ishemic and hemorrhagic complications. the...

Full description

Saved in:
Bibliographic Details
Main Authors: A. L. Komarov, E. P. Panchenko
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2015-03-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/225
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850029041231331328
author A. L. Komarov
E. P. Panchenko
author_facet A. L. Komarov
E. P. Panchenko
author_sort A. L. Komarov
collection DOAJ
description The review concerns on the testing of platelet function in Chd patients receiving antiplatelet medications.  the results are shown of the main large-scale studies demonstrating the relationship of the residual platelet activity level with the development of ishemic and hemorrhagic complications. the analysis is done of the causes of insufficient suppressing of platelet function as the response to clopidogrel. the guidelines of major international expert organizations are discussed on problem of sensitivity to aggregants testing and possible modification of antiplatelet treatment.
format Article
id doaj-art-bcd3e40ba4e24131836cccde210b65f2
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2015-03-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-bcd3e40ba4e24131836cccde210b65f22025-08-20T02:59:38Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202015-03-0103253410.15829/1560-4071-2015-3-25-34225PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONSA. L. Komarov0E. P. Panchenko1FSBI Russian Cardiological Scientific-Production Complex of the Healthcare Ministry, Moscow, RussiaFSBI Russian Cardiological Scientific-Production Complex of the Healthcare Ministry, Moscow, RussiaThe review concerns on the testing of platelet function in Chd patients receiving antiplatelet medications.  the results are shown of the main large-scale studies demonstrating the relationship of the residual platelet activity level with the development of ishemic and hemorrhagic complications. the analysis is done of the causes of insufficient suppressing of platelet function as the response to clopidogrel. the guidelines of major international expert organizations are discussed on problem of sensitivity to aggregants testing and possible modification of antiplatelet treatment.https://russjcardiol.elpub.ru/jour/article/view/225residual platelet reactivity to adpantiplatelet therapypercutaneous interventionsthrombosisbleeding
spellingShingle A. L. Komarov
E. P. Panchenko
PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
Российский кардиологический журнал
residual platelet reactivity to adp
antiplatelet therapy
percutaneous interventions
thrombosis
bleeding
title PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
title_full PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
title_fullStr PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
title_full_unstemmed PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
title_short PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
title_sort platelet function test for the assessment of thrombosis and bleeding risk in chd patients taking antiplatelet medications
topic residual platelet reactivity to adp
antiplatelet therapy
percutaneous interventions
thrombosis
bleeding
url https://russjcardiol.elpub.ru/jour/article/view/225
work_keys_str_mv AT alkomarov plateletfunctiontestfortheassessmentofthrombosisandbleedingriskinchdpatientstakingantiplateletmedications
AT eppanchenko plateletfunctiontestfortheassessmentofthrombosisandbleedingriskinchdpatientstakingantiplateletmedications